Summary of Study ST002295

This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR001307. The data can be accessed directly via it's Project DOI: 10.21228/M8S124 This work is supported by NIH grant, U2C- DK119886.

See: https://www.metabolomicsworkbench.org/about/howtocite.php

This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.

Show all samples  
Download mwTab file (text)   |  Download mwTab file(JSON)   |  Download data files (Contains raw data)
Study IDST002295
Study TitleMetabolic impact of anticancer drugs Pd2Spermine and Cisplatin on the lipophilic metabolome of liver from cell-derived xenograft mouse model of Triple-Negative Breast Cancer (part 2)
Study TypeNMR-based metabolomics
Study SummaryPlatinum (Pt(II)) drugs, e.g. cisplatin (cDDP), are some of the most used chemotherapeutic agents, yet tumor acquired resistance and high toxicity are still current drawbacks. Palladium (Pd(II))-complexes are alternatives due to similar metal coordination and promising cytotoxic properties. Metabolomics can measure the metabolic response of drug-exposed tissues, unveiling insight into drug mechanisms and new markers of drug efficacy/toxicity. The present 1H NMR metabolomics study aims to characterize the in vivo response of the impact of a Pd(II)-complex with polyamine spermine (Pd2Spm), compared to cDDP, on lipophilic metabolism of liver from cell-derived xenograft mouse model of Triple-Negative Breast Cancer.
Institute
University of Aveiro
DepartmentDepartment of Chemistry and CICECO-Aveiro Institute of Materials
LaboratoryMetabolomics from Ana M. Gil
Last NameCarneiro
First NameTatiana João
AddressCampus Universitário de Santiago, Aveiro, Aveiro, 3810-193, Portugal
Emailtatiana.joao@ua.pt
Phone+351 234 370 200
Submit Date2022-09-14
Num Groups3
Total Subjects22
Num Females22
Raw Data AvailableYes
Raw Data File Type(s)fid
Analysis Type DetailNMR
Release Date2022-12-15
Release Version1
Tatiana João Carneiro Tatiana João Carneiro
https://dx.doi.org/10.21228/M8S124
ftp://www.metabolomicsworkbench.org/Studies/ application/zip

Select appropriate tab below to view additional metadata details:


Project:

Project ID:PR001307
Project DOI:doi: 10.21228/M8S124
Project Title:Biochemical Impact of Platinum and Palladium-based Anticancer Agents – BioIMPACT
Project Type:NMR-based metabolomics
Project Summary:Platinum (Pt(II)) drugs, e.g. cisplatin (cDDP), are some of the most used chemotherapeutic agents, yet tumor acquired resistance and high toxicity are still current drawbacks. Palladium (Pd(II))-complexes are alternatives due to similar metal coordination and promising cytotoxic properties. Metabolomics can measure the metabolic response of drug-exposed tissues, unveiling insight into drug mechanisms and new markers of drug efficacy/toxicity. The present 1H NMR metabolomics study aims to characterize the in vivo response of the impact of a Pd(II)-complex with polyamine spermine (Pd2Spm), compared to cDDP, on the metabolism of several organs from healthy mice.
Institute:University of Aveiro
Department:Department of Chemistry and CICECO-Aveiro Institute of Materials
Laboratory:Metabolomics from Ana M. Gil
Last Name:Carneiro
First Name:Tatiana J.
Address:Campus Universitário de Santiago, Aveiro, Aveiro, 3810-193, Portugal
Email:tatiana.joao@ua.pt
Phone:+351926369478
Funding Source:This research was developed within the scope of the CICECO—Aveiro Institute of Materials, with references UIDB/50011/2020 and UIDP/50011/2020, financed by national funds through the Por-tuguese Foundation for Science and Technology (FCT/MEC) and when appropriate co-financed by European Regional Development Fund (FEDER) under the PT2020 Partnership Agreement. This work was also funded by the FCT through LAQV/REQUIMTE FCT UIDB/50006/2020 (C.D.), UIDB/00070/2020 (A.L.M.B.d.C and M.P.M.M.), POCI-01-0145-FEDER-0016786, and Cen-tro-01-0145-FEDER-029956 (co-financed by COMPETE 2020, Portugal 2020 and European Com-munity through FEDER). We also acknowledge the Portuguese National NMR Network (PTNMR), supported by FCT funds as the NMR spectrometer used is part of PTNMR and partially supported by Infrastructure Project Nº 022161 (co-financed by FEDER through COMPETE 2020, POCI and PORL, and the FCT through PIDDAC). M.V. thanks the FCT and the PhD Program in Medicines and Pharmaceutical Innovation (i3DU) for his PhD grant PD/BD/135460/2017 and T.J.C. thanks FCT for her PhD grant SFRH/BD/145920/2019; both grants were funded by the European Social Fund of the European Union and national funds FCT/MCTES.

Subject:

Subject ID:SU002381
Subject Type:Mammal
Subject Species:Mus musculus
Taxonomy ID:10090
Genotype Strain:CBA nude (N:NIH(S)II-nu/nu)
Age Or Age Range:6 to 7-weeks old
Gender:Female
Animal Animal Supplier:i3S Animal Facility (Porto, Portugal)
Animal Housing:ICBAS-UP Rodent Animal House Facility (Porto, Portugal)
Animal Light Cycle:12h light/dark cycles (7.00 AM lights on)
Animal Feed:ad libitum
Animal Water:ad libitum
Animal Inclusion Criteria:Healthy animails
Species Group:CBA nude (N:NIH(S)II-nu/nu)

Factors:

Subject type: Mammal; Subject species: Mus musculus (Factor headings shown in green)

mb_sample_id local_sample_id Treatment_group
SA220351xeno_L_EL_A_24b_1_2Cisplatin-treated
SA220352xeno_L_EL_A_16_1_2Cisplatin-treated
SA220353xeno_L_EL_A_25_1_2Cisplatin-treated
SA220354xeno_L_EL_A_32b_1_2Cisplatin-treated
SA220355xeno_L_EL_A_33b_1_2Cisplatin-treated
SA220356xeno_L_EL_A_14_1_2Cisplatin-treated
SA220357xeno_L_EL_A_28b_1_2Cisplatin-treated
SA220358xeno_L_EL_A_7_1_2Cisplatin-treated
SA220359xeno_L_EL_C_17_1_2Control
SA220360xeno_L_EL_C_20b_1_2Control
SA220361xeno_L_EL_C_26b_1_2Control
SA220362xeno_L_EL_C_29b_1_2Control
SA220363xeno_L_EL_C_27b_1_2Control
SA220364xeno_L_EL_C_11_1_2Control
SA220365xeno_L_EL_B_23b_1_2Pd2Spm-treated
SA220366xeno_L_EL_B_30b_1_2Pd2Spm-treated
SA220367xeno_L_EL_B_22b_1_2Pd2Spm-treated
SA220368xeno_L_EL_B_10b_1_2Pd2Spm-treated
SA220369xeno_L_EL_B_8b_1_2Pd2Spm-treated
SA220370xeno_L_EL_B_13c_1_2Pd2Spm-treated
SA220371xeno_L_EL_B_18b_1_2Pd2Spm-treated
SA220372xeno_L_EL_B_19b_1_2Pd2Spm-treated
Showing results 1 to 22 of 22

Collection:

Collection ID:CO002374
Collection Summary:At day 39 post-implantation of MDA-MB-231 cells (25G needle, 5E6 cells in 150 microliters of PBS) in the left flank of mice, and, at day 9 post-treatment with metal-based drugs, the mice were sacrificed with isoflurane, organs were excised, snap-frozen and stored at -80 ºC.
Sample Type:Liver
Collection Duration:Inferior to one minute
Storage Conditions:-80℃

Treatment:

Treatment ID:TR002393
Treatment Summary:At day 25 post-implantation, 8 animals were randomly chosen into three groups to receive the treatment with either (i) vehicle (phosphate-buffered saline, PBS) - controls, (ii) cDDP (2 mg/kg/day), or (iii) Pd2Spm (5 mg/kg/day), via intraperitoneal injection, during five consecutive days. Two control animals were excluded from the study since they developed ulcerated tumors (at day 28 post-implantation) and needed to be prematurely euthanized.
Treatment Route:Intraperitoneal injection
Treatment Dosevolume:500 microliters
Treatment Vehicle:PBS (phosphate-buffered saline solution)

Sample Preparation:

Sampleprep ID:SP002387
Sampleprep Summary:The half of liver (comprising median and left lobes) from each mouse was mechanically grounded in liquid nitrogen and samples were extracted using the biphasic methanol/ chloroform/ water (2:2:1) method. Lipophilic phases were recovered and dried. Previously to NMR acquisition, lipophilic extracts were suspended in 650 µL of CDCl3, containing 0.03% tetramethylsilane (TMS). Samples were then homogenized and transferred into 5mm NMR tubes.
Processing Storage Conditions:-80℃
Extraction Method:Biphasic method (methanol/ chloroform/ water)
Extract Storage:-80℃

Analysis:

Analysis ID:AN003749
Laboratory Name:Metabolomics Ana M. Gil
Analysis Type:NMR
Acquisition Date:April 2021
Software Version:Topspin 3.2
Results File:ST002295_AN003749_Results.txt
Units:ppm

NMR:

NMR ID:NM000252
Analysis ID:AN003749
Instrument Name:Avance III TM HD 500MHz
Instrument Type:FT-NMR
NMR Experiment Type:1D-1H
NMR Comments:1st subfolder contains raw spectra; 2nd subfolder contains manually processed spectra
Field Frequency Lock:Deuterated chloroform
Spectrometer Frequency:500MHz
NMR Probe:TXI
NMR Solvent:CDCl3
NMR Tube Size:5mm
Shimming Method:Topshim
Receiver Gain:203
Temperature:298K
Number Of Scans:512
Acquisition Time:2.34s
Relaxation Delay:2s
Spectral Width:7002.801
Zero Filling:64k
Baseline Correction Method:Manual
Chemical Shift Ref Std:TMS (tetramethylsilane)
NMR Results File:LiverLE_NMR_data.txt UNITS:ppm
  logo